Effect of Duration of Anticoagulation in the Incidence of Stroke in Patients With Left-Ventricular Thrombus

Dataset for the study of the effect of anticoagulation in the incidence of stroke and other outcomes in patients with left ventricular thrombus

“… The use of this dataset as a template for the inclusion of new patients (i.e., from other centers) will increase the power of the analysis. For instance, it seemed from our analysis that while long-term anticoagulation was largely associated with a lower risk of stroke, patients with lower embolic risk may not benefit from long-term anticoagulant treatment [1] . Subgroup analysis from other studies have also suggested a possible protective effect associated with longer anticoagulation periods [3] .…”

“…Data retrieved from the EMRs were those indicated in Tables 1–3, and the raw data is available on the attached dataset. Results are available in tables and supplementary files of the original article [1] . Data source location Cardiology department.…”

“…Hospital Universitario Ramón y Cajal Ctra de Colmenar Viejo, Km 9,100. 28034, Madrid Spain Data accessibility Analyzed data: in the original the article [1] Raw data: dataset is available at Zenodo repository. Lorente-Ros, A, & Zamorano Gómez, JL.…”

Contemporary Review of the Management of Left Ventricular Thrombus

“…17,27,30,39,40 Eight studies each (25.0%) described a median duration of OAC treatment of between 3 and 6 months, seven studies (21.9%) described a treatment duration of 6-12 months and seven studies (18.8%) described a median treatment duration of >12 months. [16][17][18][19]21,23,24,28,30,[32][33][34][35][36][37]41,43,46 The median time to LVT resolution ranged from 2 to 3.4 months for DOACs and from 4 to 9 months for VKAs, with 70-86% of patients on DOACs and 49-76% of patients on VKAs achieving LVT resolution by 12 months. 13,30,46 Five studies found a significantly shorter time to resolution with DOACs compared with VKAs.…”